INHIBIKASE THERAPEUTICS INC (IKT) Stock Balance Sheet
USA - NASDAQ:IKT - US45719W2052 - Common Stock
1.53 USD
-0.07 (-4.38%)
1.5325 USD
+0 (+0.16%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 77.74M | 56.49M | 9.17M | 7.19M | 40.75M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 9.92M | 41.05M | 4.09M | 15.86M | null | |||
| Receivables | null | null | 0 | 40.00K | 110.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 1.13M | 907.80K | 959.00K | 1.28M | 1.61M | |||
| Total Current Assets | 88.79M | 98.45M | 14.21M | 24.37M | 42.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 58.60K | 148.50K | 295.60K | 570.00K | null | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 58.60K | 148.60K | 295.60K | 570.00K | 0 | |||
| TOTAL ASSETS | 88.85M | 98.60M | 14.51M | 24.94M | 42.47M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | 250.00K | |||
| Accrued Expenses | 3.18M | 2.79M | 2.41M | 2.54M | 2.72M | |||
| Accounts Payable | 2.70M | 943.00K | 646.80K | 1.15M | 1.09M | |||
| Other Current Liabilities | 2.91M | 0 | 381.80K | null | 0 | |||
| Total Current Liabilities | 8.80M | 3.73M | 3.44M | 3.70M | 4.05M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | 0 | 90.10K | 210.00K | null | |||
| Total Non-Current Liabilities | 0 | 0 | 90.10K | 200.00K | 0 | |||
| TOTAL LIABILITIES | 8.80M | 3.73M | 3.53M | 3.90M | 4.05M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -118.01M | -94.42M | -66.90M | -47.87M | -29.82M | |||
| Additional Paid In Capital | 198.00M | 189.25M | 77.87M | 68.78M | 68.21M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 74.50K | 69.40K | 6.20K | 30.00K | 30.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -2.90K | -37.30K | 900 | 100.00K | null | |||
| Shares Outstanding | 74.52M | 69.36M | 6.19M | 4.20M | 4.19M | |||
| Tangible Book Value per Share | 1.0743 | 1.3677 | 1.7746 | 5.0095 | 9.1695 | |||
| Total Shareholders' Equity | 80.05M | 94.87M | 10.98M | 21.04M | 38.42M | |||
| TOTAL LIABILITIES AND EQUITY | 88.85M | 98.60M | 14.51M | 24.94M | 42.47M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.09 | 26.37 | 4.13 | 6.59 | 10.49 | |||
| Return On Assets (ROA) | -46.71% | -27.91% | -131.17% | -72.37% | -34.82% | |||
| Return On Equity (ROE) | -51.85% | -29.01% | -173.34% | -85.79% | -38.50% | |||
All data in USD , ROIC based on taxRate of 0.21